請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/27248
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 丁志音(Chih-yin Lew-Ding) | |
dc.contributor.author | Tseng-Yang Hung | en |
dc.contributor.author | 洪增陽 | zh_TW |
dc.date.accessioned | 2021-06-12T17:59:04Z | - |
dc.date.available | 2008-02-20 | |
dc.date.copyright | 2008-02-20 | |
dc.date.issued | 2008 | |
dc.date.submitted | 2008-01-29 | |
dc.identifier.citation | 參考文獻:
中文部分: 丁志音:健康知能與品質照護。行政院衛生署,2004年;p68-69。 內政部統計處:民國94年老人狀況調查結果摘要分析,2006年。 江慧珍:台灣民眾的就醫第二意見行為之探討。國立台灣大學衛生政策與管理研究所碩士論文,2006。 自由時報:新聞自由排名,台灣勝日美,2006.10.25。 行政院衛生署2002年5月8日衛署藥字第0910033863號公告。 行政院衛生署94年度施政績效報告,2005。 行政院衛生署網站,2007年2月。 余嘉惠:肺結核病患生活品質及其相關因素探討。中山醫學大學護理研究所碩士論文,2006。 李炳鈺:醫院門診病患用藥行為之相關因素探討。高雄醫學大學藥學研究所碩士論文,2002。 林淑琴:消費者特定求醫途徑之探討-以台北市某地區醫院全膝關節置換消費者為例。國立陽明大學衛生福利研究所碩士論文,2002。 邱培源:病患健康資訊需求與尋求行為之研究。淡江大學資訊與圖書館學系碩士論文,2001。 邱慧芬:高雄市社區民眾用藥之調查。行政院衛生署中央健康保險局,2001。 邱耀初:框架效應存在嗎?籌碼效應對風險決策之影響。中華心理學刊2003;45卷2期:171-182。 財團法人台灣醫療改革基金會:台灣醫療品質民意調查,2002年。 陳照惠:原住民肺結核病患未完成治療原因探討。中國醫藥大學醫務管理學研究所碩士論文,2007。 陳榮基:「醫生,我為什麼要開刀?」─知情同意。健康世界雜誌,2004;227期:3-3。 陳騰永:高齡者用藥資訊認知之探討。明志科技大學工業管理研究所碩士論文,2007。 彭莉琴:某醫學中心中風高血壓病人遵醫囑服藥行為階段及相關因素之探討。國立臺灣師範大學衛生教育學系碩士論文,2000。 曾明淑、黃莉汶、郭雅菱、張世龍:大台北地區民眾營養標示認知與喜好調查。Nutr Sci J. 1999;24(3):274-287。 黃盈翔、盧豐華:老年人之用藥原則。台灣醫學2003;7:385-395 楊淑婷:媒體對用藥安全的知識、態度及行為之影響。臺北醫學大學醫務管理學研究所碩士論文,2006。 劉建財等:藥物資訊網路系統。台灣醫學2003;7卷4期:485-491。 蔡甫昌:「醫師,您獲得病患同意了嗎?」知情同意的理論與實務。健康世界雜誌,2004;222期:59-62 鄭志忠:醫療糾紛案件處理之探討-以台灣醫療改革基金會收案對象為例。臺北醫學大學醫務管理學研究所,2003。 盧瑞芬、謝啟瑞:醫療經濟學。2004年10月八刷,p.7。 英文部分: Bamgbade O. Anaesthetic drug information leaflets for the patient or for the doctor? Anaesthesia 2001; 56: 1213±4. Barsky AJ, Saintfort R, Rogers MP, et al. Nonspecific medication side effects and the nocebo phenomenon. JAMA, 2002;6;287, 622–7. Berry DC, Michas IC, Gillie T, et al. What do patients want to know about their medicines and what do doctors want to tell them? A comparative study. Psychol Health 1997; 12:467-80. Bjerrum L, Foged A. Patient Information leaflets–helpful guidance or a source of confusion? pharmacoepidemiology and drug safety 2003; 12: 55–59. Cullen G et al. Patients’ knowledge of adverse reactions to current medications. Br J Clin Pharmacol 2006; 62(2): 232–236. Davis J. Riskier Than We Think? The Relationship Between Risk Statement Completeness and Perceptions of Direct to Consumer Advertised Prescription Drugs. Journal of Health Communication. 2000; 5: 349-69. Davis TC et al. Low Literacy Impairs Comprehension of Prescription Drug Warning Labels. J GEN INTERN MED 2006; 21:847–851. Davis TC et al. Reading Ability of Parents Compared With Reading Level of Pediatric Patient Education Material. Pediatrics, 1994;Vol 93 No.3. Dusing R et al. Compliance with drug therapy—new answers to an old question Nephrol Dial Transplant. 2001 16:1317-1321. Edwards A. Presenting Risk Information: A Review of the Effects of ‘framing’ and Other Manipulations on Patient Outcomes. Journal of Health Communication. 2001; 6(1): 61-82. European Commission, D-G III. A guideline on the packaging information of medical products for human use authorized by the community. Brussel: European Commission; 1997. Gillies MA, Baldwin FJ. Do patient information booklets increase perioperative anxiety? Eur J Anaesthesiol 2001; 18: 620±2. Hahn RA. The Nocebo Phenomenon: Concept, Evidence, and Implications for Public Health. PREVENTIVE MEDICINE 1997; 26: 607–611. Health literacy: report of the Council of Scientific Affairs. Ad Hoc Committee on Health Literacy for the Council on Scientific Affairs, American Medical Association. JAMA 1999;281:552-7. Knapp P, Berry DC, Raynor DK. Testing two methods of presenting side effect risk information about common medicines. Int J Pharm Pract 2001;9(Suppl):R6. Koo MB et al. Enhancing patient education about medicines: factors influencing reading and seeking of written medicine information. Health Expectations 2006; 9: pp.174–187. Kripalan S et al. Predictors of Medication Self-management Skill in a Low-literacy Population. J GEN INTERN MED 2006; 21:852–856. Makus R. Ethics and Internet Healthcare: An Ontological Reflection. Cambridge Quarterly of Healthcare Ethics. 2001; 10(2): 127-36. Morris LA et al. Effects of Written Drug Information on Patient Knowledge and Compliance: A Literature Review. Am. J. Public Health. 1979; 69:47-52. Myers MG, Cairns JA, Singer J. The consent form as a possible cause of side effects. Clin Pharmacol Ther 1987;42:250–3. Nair K et al. What patients want to know about their medications. Can Fam Physician 2002;48:104-110. Nielsen-Bohlman L, Panzer AM, Kindig DA, eds. Health Literacy: A Prescription to End Confusion. Washington, DC: National Academies Press 2004. Nutbeam D. Health literacy as a public health goal: a challenge for contemporary health education and communication strategies into the 21st century. Health Promotion International, September 2000;Vol. 15, No. 3, 259-267. Oldman M et al. Drug patient information leaflets in anaesthesia: effect on anxiety and patient satisfaction. British Journal of Anaesthesia 2004;92 (6): 854±8. Paoloni CC, Arrowsmith JE. Patient information leaflets for anaesthetic drugs. Anaesthesia 2000; 55: 911. Raynor DK et al. We are the experts: people with asthma talk about their medicine information needs. Patient Education and Counseling 2004; 53:167–174. Schommer JC, Doucette WR, Worley MM. Processing prescription drug information under different conditions of presentation. Patient Education and Counseling 2001;43:49-59. Shaughnessy AF. Common drug interaction in the elderly. Emerg Med 1992;24:21-32. Shrank WH et al. Prescription Drug Labels: A Critical Review. The American College of Physicians Foundation, Nov. 2006. Shrank WH et al. The Variability and Quality of Medication Container Labels. Arch Intern Med. 2007;167(16):1760-1765. Svarstad BL et al. Evaluation of Written Prescription Information Provided in Community Pharmacies: A Study in Eight States. J Am Pharm Assoc.2003;43:383–93. Svarstad BL et al. Expert and Consumer Evaluation of Patient Medication Leaflets Provided in U.S. Pharmacies. J Am Pharm Assoc. 2005;45:443–451. The American College of Physicians Foundation. Improving Prescription Drug Container Labeling in the United States. Rx Container Label White Paper, October 12, 2007. Tversky A, Kahneman D. The Framing of Decisions and the Psychology of Choice. Science 1981;211:453-58 Verdu F , Castello A. Non-compliance: a side effect of drug information leaflets. J. Med. Ethics 2004;30:608-9. Vinker S et al. The Effect of Drug Information Leaflets on Patient Behavior. IMAJ 2007;9:383–386. Wallace LS, Roskos SE, Weiss BD. Readability characteristics of consumer medication information for asthma inhalation devices. J Asthma 2006; 43:375-8. Ziegler DK et al. How much information about adverse effects of medication do patients want from physicians? Arch Intern Med 2001;161:706-13. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/27248 | - |
dc.description.abstract | 摘要
不良的用藥標示,包括過多或過少的資訊提供,經常是影響用藥依從性(medication adherence)的一個潛在因素,在倫理上,醫療有關的資訊應該充分提供給病患,但所謂「足夠的」資訊指的是什麼?資訊根據多少的證據才算足夠?數量需要呈現多少?誰來決定資訊的呈現?以及,要讓這樣的「足夠」去做什麼?在本研究所要探討的藥袋副作用標示,也經常面臨到這樣的問題,這些問題應該會引起許多的討論,並仍持續考驗著醫病雙方的智慧。 在過去用藥資訊不甚透明的時代,直到今天大多數醫療院所合乎標示的規定,當中又以副作用的標示屬空前的措施,呈現一種醫病雙方皆不曾有過的新時代與新體驗。2007年我國公布施行的藥師法第十九條修正,藥師於藥劑之容器包裝上應記明警語或副作用,使得這項標示已非醫療道德上的高標準,而是法律上所規範的最低標準了。 為了進一步了解民眾究竟怎樣看待與利用藥袋標示,尤其是藥物副作用標示的部份,對它的需求以及偏好,在人群中的分佈的情形如何?有沒有副作用經驗信念上的相關?為了得到這些解答,於是以制式問卷及便利取樣之方式來進行資料收集與研究。 研究結果有以下重要發現: 1. 多數的民眾(67.3%)在每次領藥時會閱讀與使用藥袋副作用標示,但年輕族群比率顯著偏低;而經驗上曾因為只看到藥袋標示的副作用而放棄服藥者,比率則顯著較高。 2. 民眾多數(56.9%)認為藥袋非常有必要標示副作用,其中以年輕、高學歷、具有副作用相關經驗者則顯著認為有標示的必要。 3. 在副作用標示數量上,大多數民眾(73.4%)認為應該全數標示,而偏好全數標示與民眾特質、副作用經驗及信念大致無關,僅年輕族群略有顯著之偏好。 4. 大多數民眾(74.6%)可以同意以「警語」取代副作用標示,但需要長期服藥者與信念上覺得藥物都有副作用者,其同意之傾向則顯著較低。 5. 三項建議標示裡,以「主要適應症」(major indications)獲多數民眾(57.7%)認為是最重要的標示,「主要副作用」(major side effects)則居末(16.7%),教育程度最高與最低兩端,以及需要長期服藥者認為副作用標示最為重要的比率顯著偏低。 大致而言,民眾對藥袋副作用標示的期待,存有社會人口特質與個人副作用經驗與信念的差異。具有指示屬性與資訊櫥窗功能標示的藥袋,則是多數民眾期待它扮演的角色,超越實際的副作用標示。建議實務上應同時配合其它用藥教育的方式,來強化病患自我照護與知藥用藥的能力與權利。 | zh_TW |
dc.description.abstract | Abstract
In medically ethic terms, patients should be well-informed, and optimal information provided -- inadequate or superfluous – challenges the patients’ adherence of medication. This lends to the significance of such scholarly inquiries as: what is “optimal” amount disclose of medical information; upon what confidence-level these labeling are based; who exerts the legitimate power to determine with what effects. All of these underline the importance of an issue which remains under-researched and unanswered for medical professionals. In Taiwan, the debate regarding the optimal amount has surfaced over the decade, challenging the doctor-patient relationships. The legal and law enforcement agencies saw it as an opportunity to inform the publics and increase the transparency of labeling. Given these good deeds, in a major revision of the pharmacist law in 2007, an additional requirement was mandated to disclose the information better suited what patients need to know, among which label side effects and warnings were championed as unprecedented and progressive move. Indeed, witnessing was the huge stride: the pharmacies across Taiwan have improved the labeling system in response to the change. In this context, this study is conducted to analyze how the patients in Taiwan perceive and adhere with these labels with what effect. It focuses on how the perception of side-effect labeling interacts with some demographic factors such as sex, age and medical history. A structured questionnaire was formulated to help collect data using convenience sampling scheme. The results are shown as below: 1. While most patients (67.3 %) read the side effect labeling; younger people pay significantly less attention on it. Those who have given up on medication due to the side effect labeling are likely more aware of these labels. 2. Side effect labeling is considered as necessary (56.9%). Significantly more demanding was found among the young, highly-educated and those who were affected by the side effects. 3. A large percentage of patients (73.4%) think that all side effects should be labeled. These patients are not correlated with any other characteristics of personalities or experiences. 4. Most patients (74.6%) agreed that side effect labels can be replaced with warning statement. However, this is not applicable to the patients suffering from chronic illnesses or believing side effects are ubiquitous. 5. Of three important labels, “major indications” were found most important (57.7%); whereas major side effects are the least important. The most and least educated patients, or chronic illness sufferers value the label of side effect less. Although the side effect labeling is important information disclosed, the expectation for the labeling from the public varies, depending on socio-demographic and medical background. Not only expected to instructional, the labeling on drug containers (or bags) has also become a place to display educational information beyond the disclosure of side effects. At the practice level, this study suggests that education programs should be offered to improve knowledge of medication and self-care for patients. | en |
dc.description.provenance | Made available in DSpace on 2021-06-12T17:59:04Z (GMT). No. of bitstreams: 1 ntu-97-P94845106-1.pdf: 1217450 bytes, checksum: 17ed5c65288f1eb6f60e3fa60ddfb1cf (MD5) Previous issue date: 2008 | en |
dc.description.tableofcontents | 目 錄
頁數 致謝 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ i 摘要 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ ii Abstract ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ iv 目錄 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ vi 圖表目錄 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ ix 第一章 緒論 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 1 第一節 研究背景 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 1 第二節 研究目的 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 3 第二章 文獻探討 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 5 第ㄧ節 藥袋標示演進過程 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 5 第二節 國內外藥物標示的現況 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 9 第三節 用藥資訊的告知與健康識讀 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 12 第四節 副作用經驗信念與服藥依從性 ‥‥‥‥‥‥‥‥‥‥‥‥‥ 15 第五節 藥物資訊的呈現與框架效果 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 18 第六節 病患健康資訊性質與數量之搜尋 ‥‥‥‥‥‥‥‥‥‥‥‥ 20 第三章 研究方法 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 25 第一節 研究對象 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 25 第二節 抽樣方法 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 25 第三節 研究工具 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 26 第四節 研究變項 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 27 第五節 資料收集 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 29 第六節 研究架構 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 30 第七節 資料分析與處理 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 31 第四章 研究結果 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 32 第一節 調查資料的樣本特質描述 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 32 第二節 推論統計分析 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 46 第五章 討論 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 69 第一節 藥袋資訊櫥窗的角色與標示效應 ‥‥‥‥‥‥‥‥‥‥‥‥ 69 第二節 藥袋副作用標示之屬性與延伸功能 ‥‥‥‥‥‥‥‥‥‥‥ 73 第三節 對副作用標示之特殊反應 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 77 第四節 研究限制 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 81 第五節 結論與建議 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 82 參考文獻 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 84 圖表目錄 表1-1:藥袋標示意見調查 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 3 表2-1:我國藥品包裝容器標示法令之現況 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 6 表2-2:美國藥品包裝容器標示現況與民間團體要求情形 ‥‥‥‥‥‥‥‥ 8 表2-3:藥物書面資訊實施情況一覽表 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 9 表2-4:美國分歧的標示系統 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 10 表3-1:研究變項及其定義 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 27 表4-1:研究樣本之社會人口特質 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 33 表4-2:長期服藥經驗與副作用經驗及信念 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 36 表4-3:藥袋資訊使用與藥物資訊搜尋 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 39 表4-4:藥袋副作用標示認知及偏好 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 44 表4-5:社會人口特質、長期服藥經驗及藥袋資訊使用與藥物資訊搜尋之雙變項分析 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 49 表4-6:社會人口特質、長期服藥經驗及藥袋副作用標示認知與偏好 ‥‥‥ 54 表4-7:藥物副作用經驗與信念及藥袋副作用資訊使用、藥物副作用資訊搜尋之雙變項分析 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 58 表4-8:藥物副作用經驗與信念及藥袋副作用標示認知及偏好 ‥‥‥‥‥‥ 63 表4-9:副作用經驗與信念之交叉分析 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 65 表4-10:藥袋副作用標示需求與影響因素之邏輯斯迴歸 ‥‥‥‥‥‥‥‥‥ 68 圖2-1:美國藥物包裝容器標示 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 11 圖2-2:文獻上非遵囑性的討論引用次數趨勢 ‥‥‥‥‥‥‥‥‥‥‥‥‥ 16 圖2-3:病患「如何」與「為何」搜尋資訊的模型 ‥‥‥‥‥‥‥‥‥‥‥‥ 21 圖2-4:病患藥物資訊的來源 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 22 | |
dc.language.iso | zh-TW | |
dc.title | 藥袋副作用標示-民眾需求之探討 | zh_TW |
dc.title | The Lay Perspective of Labeling Side Effects
on Drug Containers | en |
dc.type | Thesis | |
dc.date.schoolyear | 96-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 季瑋珠(Wei-chu Chie),蔡慈儀(Tzu-i Tsai) | |
dc.subject.keyword | 藥袋標示,副作用,警語,用藥依從性,藥物資訊, | zh_TW |
dc.subject.keyword | drug labeling,side effect,precaution/warning,medication adherence,drug information, | en |
dc.relation.page | 88 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2008-01-29 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 衛生政策與管理研究所 | zh_TW |
顯示於系所單位: | 健康政策與管理研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-97-1.pdf 目前未授權公開取用 | 1.19 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。